Gastrointestinal cancer: Rationale for metronomic chemotherapy in phase III trials

Robert S. Kerbel, Axel F Grothey

Research output: Contribution to journalArticle

12 Citations (Scopus)
Original languageEnglish (US)
Pages (from-to)313-314
Number of pages2
JournalNature Reviews Clinical Oncology
Volume12
Issue number6
DOIs
StatePublished - Jun 30 2015

Fingerprint

Antineoplastic Combined Chemotherapy Protocols
Gastrointestinal Neoplasms
Colorectal Neoplasms
Drug Therapy

ASJC Scopus subject areas

  • Oncology

Cite this

Gastrointestinal cancer : Rationale for metronomic chemotherapy in phase III trials. / Kerbel, Robert S.; Grothey, Axel F.

In: Nature Reviews Clinical Oncology, Vol. 12, No. 6, 30.06.2015, p. 313-314.

Research output: Contribution to journalArticle

Kerbel, Robert S. ; Grothey, Axel F. / Gastrointestinal cancer : Rationale for metronomic chemotherapy in phase III trials. In: Nature Reviews Clinical Oncology. 2015 ; Vol. 12, No. 6. pp. 313-314.
@article{085b1bc1b3504560a0bf8a31ee6265f6,
title = "Gastrointestinal cancer: Rationale for metronomic chemotherapy in phase III trials",
author = "Kerbel, {Robert S.} and Grothey, {Axel F}",
year = "2015",
month = "6",
day = "30",
doi = "10.1038/nrclinonc.2015.89",
language = "English (US)",
volume = "12",
pages = "313--314",
journal = "Nature Reviews Clinical Oncology",
issn = "1759-4774",
publisher = "Nature Publishing Group",
number = "6",

}

TY - JOUR

T1 - Gastrointestinal cancer

T2 - Rationale for metronomic chemotherapy in phase III trials

AU - Kerbel, Robert S.

AU - Grothey, Axel F

PY - 2015/6/30

Y1 - 2015/6/30

UR - http://www.scopus.com/inward/record.url?scp=84930181366&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84930181366&partnerID=8YFLogxK

U2 - 10.1038/nrclinonc.2015.89

DO - 10.1038/nrclinonc.2015.89

M3 - Article

C2 - 25963090

AN - SCOPUS:84930181366

VL - 12

SP - 313

EP - 314

JO - Nature Reviews Clinical Oncology

JF - Nature Reviews Clinical Oncology

SN - 1759-4774

IS - 6

ER -